chr4-10048517-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000506583.5(SLC2A9):c.-176+6316G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.765 in 151,920 control chromosomes in the GnomAD database, including 45,038 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.77 ( 45038 hom., cov: 30)
Consequence
SLC2A9
ENST00000506583.5 intron
ENST00000506583.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.943
Publications
21 publications found
Genes affected
SLC2A9 (HGNC:13446): (solute carrier family 2 member 9) This gene encodes a member of the SLC2A facilitative glucose transporter family. Members of this family play a significant role in maintaining glucose homeostasis. The encoded protein may play a role in the development and survival of chondrocytes in cartilage matrices. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.812 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC2A9 | ENST00000506583.5 | c.-176+6316G>A | intron_variant | Intron 1 of 13 | 5 | ENSP00000422209.1 | ||||
| SLC2A9 | ENST00000513129.1 | c.-41+6316G>A | intron_variant | Intron 1 of 5 | 3 | ENSP00000426800.1 | ||||
| SLC2A9-AS1 | ENST00000733256.1 | n.319-7342C>T | intron_variant | Intron 2 of 3 |
Frequencies
GnomAD3 genomes AF: 0.766 AC: 116218AN: 151802Hom.: 45009 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
116218
AN:
151802
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.765 AC: 116292AN: 151920Hom.: 45038 Cov.: 30 AF XY: 0.759 AC XY: 56393AN XY: 74258 show subpopulations
GnomAD4 genome
AF:
AC:
116292
AN:
151920
Hom.:
Cov.:
30
AF XY:
AC XY:
56393
AN XY:
74258
show subpopulations
African (AFR)
AF:
AC:
31706
AN:
41400
American (AMR)
AF:
AC:
9610
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
2468
AN:
3466
East Asian (EAS)
AF:
AC:
2667
AN:
5152
South Asian (SAS)
AF:
AC:
3256
AN:
4804
European-Finnish (FIN)
AF:
AC:
8442
AN:
10574
Middle Eastern (MID)
AF:
AC:
204
AN:
294
European-Non Finnish (NFE)
AF:
AC:
55594
AN:
67958
Other (OTH)
AF:
AC:
1584
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1354
2708
4061
5415
6769
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
854
1708
2562
3416
4270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2231
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.